CMDC

China National Medical Device Co., Ltd. (CMDC) is identified by Sinopharm as the business carrier for medical-equipment development under China National Pharmaceutical Group and Sinopharm Group. [1] [2] Sinopharm’s group profile places CMDC alongside China National Scientific Instruments and Materials as a core platform in its medical-equipment manufacturing strategy. [1] [2]

CMDC’s own group description emphasizes a medical-equipment distribution network and comprehensive medical-device services rather than a single device product. [2] It says the company has launched the FLI+SPD 3.0 intelligent-upgrade solution, is building a digital supply-chain platform and has developed research-management capabilities; it also describes CMDC as one of the first demonstration units for comprehensive use of unique-device-identification (UDI) systems. [2]

The company operates within a wider Sinopharm healthcare and supply-chain ecosystem. [1] Sinopharm says its pharmaceutical logistics business serves more than 700,000 end customers, including primary, secondary and tertiary hospitals, retail pharmacies, distributors and grassroots medical institutions. [1] That parent-group figure is not a CMDC-only customer count, but it helps describe the distribution infrastructure surrounding the medical-device platform. [1]

CMDC’s relevance to international technology partnerships is illustrated by its February 2023 agreement with GE Healthcare China. [3] The parties announced a Chinese joint venture for research, development and manufacturing of high-end medical-imaging equipment, with CMDC holding the majority stake; Sinopharm characterized the project as a way to combine the parties’ capabilities and accelerate domestic registration, market launch and production of imaging equipment. [3]